Filed (PHiled). Greater than 1-2 years since publication

Management advances for congenital diaphragmatic hernia: integrating prenatal and postnatal perspectives

Ahmet A. Baschat, Suneetha Desiraju, Meghan L. Bernier, Shaun M. Kunisaki, Jena L. MillerJohns Hopkins University School of Medicine.United States Translational PediatricsTransl Pediatr 2024; 13: 643-662DOI: 10.21037/tp-23-602 AbstractIn congenital diaphragmatic hernia (CDH), abdominal organs are displaced into the chest, compress the lungs, and cause mediastinal shift. This contributes to development of pulmonary hypoplasia and hypertension, which […]

Management advances for congenital diaphragmatic hernia: integrating prenatal and postnatal perspectives Read More »

Interventional heart catheterization to close atrial septal defect, patent ductus arteriosus, ventricular septal defect in a 3.5-year-old girl; a case report study

Zahra Kamiab, Reza DerakhshanRafsanjan University of Medical Sciences. Kerman University of Medical Sciences.Iran Journal of Surgigal Case ReportsJ Surg Case Rep 2024; DOI: 10.1093/jscr/rjae161 AbstractThe aim of this study was to introduce an interventional heart catheterization to close patent ductus arteriosus (PDA), ventricular septal defect (VSD), atrial septal defect (ASD), and pulmonary hypertension without complications from

Interventional heart catheterization to close atrial septal defect, patent ductus arteriosus, ventricular septal defect in a 3.5-year-old girl; a case report study Read More »

Direct prostacyclin transition in pediatric patients with pulmonary hypertension

Kelly Merrill, Anne Davis, Emma Jackson, Meredith Riker, Christa Kirk, Delphine YungSeattle Children’s Hospital and University of Washington School of Medicine.United States Pulmonary CirculationPulm Circ 2024; 14: DOI: 10.1002/pul2.12373 AbstractPediatric patients with pulmonary arterial hypertension (PAH) are commonly treated with the prostacyclin analog treprostinil in IV, SQ, inhaled or oral form, or the prostacyclin receptor agonist

Direct prostacyclin transition in pediatric patients with pulmonary hypertension Read More »

Tailoring of Bilosomal Nanogel for Augmenting the Off-Label Use of Sildenafil Citrate in Pediatric Pulmonary Hypertension

Bjad K. Almutairy, El-Sayed Khafagy, Mohammed F. Aldawsari, Abdullah Alshetaili, Hadil Faris Alotaibi, Amr Selim Abu LilaPrince Sattam Bin Abdulaziz University. Suez Canal University. Princess Nourah Bint AbdulRahman University. Zagazig University. University of Hail.Saudi Arabia and Egypt American Chemical Society OmegaACS Omega 2024; 9: 19536-19547DOI: 10.1021/acsomega.4c01133 AbstractPediatric pulmonary hypertension is a serious syndrome with significant morbidity

Tailoring of Bilosomal Nanogel for Augmenting the Off-Label Use of Sildenafil Citrate in Pediatric Pulmonary Hypertension Read More »

A neonatal rat model of pulmonary vein stenosis

Debao Li, Lisheng Qiu, Haifa Hong, Hao Chen, Peibin Zhao, Yingying Xiao, Hao Zhang, Qi Sun, Lincai YeShanghai Children’s Medical Center and Shanghai Jiao Tong University. Second Affiliated Hospital and Yuying Children’s Hospital and Wenzhou Medical University.China Cell and BioscienceCell Biosci 2023; 13:DOI: 10.1186/s13578-023-01058-8 AbstractObjectives: Pulmonary vein stenosis (PVS), one of the most challenging clinical problems in

A neonatal rat model of pulmonary vein stenosis Read More »

Targeted Rapamycin Delivery via Magnetic Nanoparticles to Address Stenosis in a 3D Bioprinted in Vitro Model of Pulmonary Veins

Liqun Ning, Stefano Zanella, Martin M. Tomov, Medhi Salar Amoli, Linqi Jin, Bouen Hwang, Maher Saadeh, Huang Chen, Sunder Neelakantan, Lakshmi Prasad Dasi, Reza Avazmohammadi, Morteza Mahmooudi, Holly D. Bauser-Heaton, Vahid SerpooshanEmory University School of Medicine, Children’s Healthcare of Atlanta and Georgia Institute of Technology. Cleveland State University. Texas A&M University. Michigan State University. United

Targeted Rapamycin Delivery via Magnetic Nanoparticles to Address Stenosis in a 3D Bioprinted in Vitro Model of Pulmonary Veins Read More »

Correlating Severity of Pulmonary Hypertension by Echocardiogram with Mortality in Premature Infants with Bronchopulmonary Dysplasia

Rachel D. Torok, Robert A. Gardner, Piers C.A. Barker, Andrew W. McCrary, Jennifer S. Li, Christoph P. Hornik, Matthew M. Laughon, Wesley M. JacksonDuke University Medical Center. University of North Carolina at Chapel Hill. United States American Journal of PerinatologyAm J Perinatol 2024; DOI: 10.1055/s-0044-1786544 AbstractObjective: Bronchopulmonary dysplasia (BPD) is the most common complication of preterm birth. Infants with BPD are at increased risk

Correlating Severity of Pulmonary Hypertension by Echocardiogram with Mortality in Premature Infants with Bronchopulmonary Dysplasia Read More »

The prognostic value of prognostic nutritional index in postoperative onset of PAH in children with isolated VSD: a prospective cohort study based on propensity score matching analysis

Zeying Zhang, Jing Su, Chenyang Li, Shirui Cao, Chao Sun, Qiuzhen Lin, Haiyan Luo, Zhenghui Xiao, Yunbin Xiao, Qiming LiuSecond Xiangya Hospital of Central South University. Hunan Children’s Hospital. China Frontiers in PediatricsFront Pediatr 2024; 12:DOI: 10.3389/fped.2024.1292786 AbstractBackground: The mechanism of pulmonary arterial hypertension (PAH) after surgery/intervention for isolated venticlular septal defect (VSD) in children is unknown.

The prognostic value of prognostic nutritional index in postoperative onset of PAH in children with isolated VSD: a prospective cohort study based on propensity score matching analysis Read More »

Dynamically stiffening biomaterials reveal age- and sex-specific differences in pulmonary arterial adventitial fibroblast activation

Mikala C. Mueller, Yanmei Du, Lori A. Walker, Chelsea M. MaginUniversity of Colorado, Anschutz Medical Campus.United States Matrix Biology PlusMatrix Biol Plus 2024; DOI: 10.1016/j.mbplus.2024.100145 AbstractRespiratory diseases like pulmonary arterial hypertension (PAH) frequently exhibit sexual dimorphism. Female PAH patients are more susceptible to the disease but have increased survival rates. This phenomenon is known as the

Dynamically stiffening biomaterials reveal age- and sex-specific differences in pulmonary arterial adventitial fibroblast activation Read More »

Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension

Haiyang Tang, Akash Gupta, Seth A. Morrisroe, Changlei Bao, Tae-Hwi Schwantes-An, Geetanjali Gupta, Shuxin Liang, Yanan Sun, Aiai Chu, Ang Luo, Venkateswaran Ramamoorthi Elangovan, Shreya Sangam, Yinan Shi, Samisubbu R. Naidu, Jia-Rong Jheng, Sultan Ciftci-Yilmaz, Noel A. Warfel, Louise Hecker, Sumegha Mitra, Anna W. Coleman, Katie A. Lutz, Michael W. Pauciulo, Yen-Chun Lai, Ali Javaheri,

Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension Read More »

Scroll to Top